186590-36-3 Usage
Uses
Used in Chemical Synthesis:
4,5-Difluoro-2-hydroxybenzonitrile is used as a key intermediate in the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and specialty chemicals. Its unique structure allows for selective functionalization and modification, making it a valuable building block in organic chemistry.
Used in Analytical Chemistry:
4,5-Difluoro-2-hydroxybenzonitrile crystals have been used as a practical means for monitoring, imaging, and other purposes. Their distinct chemical and physical properties make them suitable for use in analytical techniques such as chromatography, spectroscopy, and electrochemistry.
Used in Material Science:
Due to its unique structure and properties, 4,5-difluoro-2-hydroxybenzonitrile has potential applications in the development of new materials with specific properties. It can be used in the synthesis of polymers, coatings, and other materials with tailored characteristics for various industries.
Used in Environmental Applications:
4,5-Difluoro-2-hydroxybenzonitrile can be employed in environmental monitoring and remediation efforts. Its chemical properties may allow it to be used in the detection and removal of pollutants, as well as in the development of eco-friendly materials and processes.
Check Digit Verification of cas no
The CAS Registry Mumber 186590-36-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,6,5,9 and 0 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 186590-36:
(8*1)+(7*8)+(6*6)+(5*5)+(4*9)+(3*0)+(2*3)+(1*6)=173
173 % 10 = 3
So 186590-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H3F2NO/c8-5-1-4(3-10)7(11)2-6(5)9/h1-2,11H
186590-36-3Relevant academic research and scientific papers
NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE
-
Page/Page column 22, (2008/06/13)
[From equivalent EP1710233A1] The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R1 is hydrogen or lower alkyl; R2 is lower alkyl, halo-lower alkyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, arylalkenyl, aryloxy-lower alkyl, heteroaryl, heteroaryl-lower alkyl, etc; R3, R4, R5 and R6 are each hydrogen, halogen, cyano, lower alkyl, halo-lower alkyl, lower alkoxy, hydroxy, aryl, etc; provided that at least one of R3, R4, R5 and R6 is other than hydrogen. Compound (I) of the present invention shows a potent adenosine A2A receptor antagonistic activity, and are useful for treating or preventing a disease mediated by adenosine A2A receptors such as motor function disorders, depression, anxiety disorders, cognitive function disorders, cerebral ischemia disorders, restless legs syndrome and the like.
